Keyword Connections

parkinson's disease

Journals

26

1 Frontiers in public health

2 Revista de saude publica

3 inhalation toxicology

4 neuroimage clinical

5 neurobiology of aging

6 Journal of psychosomatic research

7 neurology india

8 NeuroImage

9 parkinson's disease

10 current opinion in structural biology

11 neurologia (barcelona, spain)

12 neurobiology of disease

13 Journal of computational biology : a journal of computational molecular cell biology

14 frontiers in neurology

15 physiological measurement

16 npj parkinson's disease

17 Neuromodulation : journal of the International Neuromodulation Society

18 Journal of the neurological sciences

19 Human movement science

20 movement disorders : official journal of the movement disorder society

21 pharmacoeconomics

22 cortex; a journal devoted to the study of the nervous system and behavior

23 antioxidants & redox signaling

24 european neuropsychopharmacology : the journal of the european college of neuropsychopharmacology

25 neurology genetics

26 journal of neuropsychology

Research Groups

0

No Research Group Connected

Bibliographies

156

1 Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: Results from a pilot randomized controlled trial.

2 A New Approach for Sampling Ordered Parameters in Probabilistic Sensitivity Analysis.

3 Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's disease.

4 Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology.

5 The Parkinson's Disease Mendelian Randomization Research Portal.

6 Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.

7 Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

8 Impairment in Theory of Mind in Parkinson's Disease Is Explained by Deficits in Inhibition.

9 Analyzing Apomorphine-Mediated Effects in a Cell Model for Parkinson's Disease with Partial Least Squares Structure Equation Modeling.

10 Therapeutic effects of forced exercise cycling in individuals with Parkinson's disease.

11 Advances in molecular simulations of protein mechanical properties and function.

12 Boxing for Parkinson's Disease: Has Implementation Accelerated Beyond Current Evidence?

13 Strategic Timing of Glial Expression Results in Either Schizophrenia-Like or Parkinsonian Behavior in Mice.

14 Neurotoxicity following acute inhalation of aerosols generated during resistance spot weld-bonding of carbon steel.

15 Parkinson's disease compromises the appraisal of action meanings evoked by naturalistic texts.

16 Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.

17 Speech rate in Parkinson's disease: A controlled study.

18 Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.

19 Kinematic gait parameters for older adults with Parkinson's disease during street crossing simulation.

20 Development of an instrument to measure the cultural competence of health care workers.

21 A Scientometric Analysis and Visualization of Research on Parkinson's Disease Associated With Pesticide Exposure.

22 Impulse control disorders in Parkinson's disease versus in healthy controls: A different predictive model.

23 Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.

24 Impulse control disorders in Parkinson's disease: Review of pathophysiology, epidemiology, clinical features, management, and future challenges.

25 2.246 THE EFFICACY AND SAFETY OF TOLCAPONE IN PATIENTS WITH PARKINSON'S DISEASE

26 increase of eeg spectral theta power indicates higher risk of the development of severe cognitive decline in parkinson’s disease after 3 years

27 "high doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in parkinson's disease patients

28 the impact of depression on survival of parkinson's disease patients: a five-year study o impacto da depressão na sobrevida de pacientes com doença de parkinson: cinco anos de estudo

29 effect of levodopa on interleukin-15 and rantes circulating levels in patients affected by parkinson's disease

30 brain atrophy and reorganization of structural network in parkinson's disease with hemiparkinsonism

31 stem cell treatment for age-related neurodegenerative diseases

32 the potential of epigenetic therapies in neurodegenerative diseases

33 apolipoprotein eε4: a biomarker for executive dysfunction among parkinson's disease patients with mild cognitive impairment

34 the p-type atpase pa1429 regulates quorum-sensing systems and bacterial virulence

35 risc in pd: the impact of micrornas in parkinson’s disease cellular and molecular pathogenesis

36 white matter changes-related gait and executive function deficits: associations with age and parkinson's disease

37 cannabidiol as a promising strategy to treat and prevent movement disorders?

38 vitamin c-induced epigenetic modifications in donor nscs establish midbrain marker expressions critical for cell-based therapy in parkinson's disease

39 dopamine and the biology of creativity: lessons from parkinson’s disease

40 functional correlates of optic flow motion processing in parkinson’s disease

41 advancing stem cell models of alpha-synuclein gene regulation in neurodegenerative disease

42 konstantin n. tretiakoff in brazil a historical perspective and discussion of his contribution to brazilian neuroscience konstantin n. tretiakoff no brasil: uma perspectiva histórica e discussão de sua contribuição à neurociência brasileira

43 connectivity analysis is essential to understand neurological disorders

44 the association of thyroid disease and oral lichen planus: a literature review and meta-analysis

45 dopamine modulates striato-frontal functioning during temporal processing

46 nitric oxide-soluble guanylyl cyclase-cyclic gmp signaling in the striatum: new targets for the treatment of parkinson's disease?

47 Associations of Ozone and PM2.5 Concentrations With Parkinsonʼs Disease Among Participants in the Agricultural Health Study

48 The Effect of Forced Exercise on Striatal and Serum Serotonin Levels in a Parkinson’s Mouse Model

49 Effectiveness of technological interventions on psychosocial well-being and perception of technological interventions among people with Parkinson's disease: A systematic review.

50 Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease.

51 Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease.

52 Delusions and visual hallucinations in a patient with Parkinson's disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert.

53 Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification.

54 Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation.

55 Deep brain stimulation for Parkinson's disease modulates high-frequency evoked and spontaneous neural activity.

56 Assessment of cardiorespiratory fitness using submaximal protocol in older adults with mood disorder and Parkinson's disease

57 Outcomes from deep brain stimulation targeting subthalamic nucleus and caudal zona incerta for Parkinson's disease.

58 AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease.

59 Early Experience With New Generation Deep Brain Stimulation Leads in Parkinson's Disease and Essential Tremor Patients.

60 A Stage-Based Approach to Therapy in Parkinson's Disease.

61 The embodiment of language in tremor-dominant Parkinson's disease patients

62 Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson's disease

63 Clinical profile of parkinson's disease: Experience of niger

64 Validity of MobilityLab (version 2) for gait assessment in young adults, older adults and Parkinson's disease.

65 Measuring Hand Dexterity in People With Parkinson's Disease: Reliability of Pegboard Tests.

66 The CuePed Trial: How Does Environmental Complexity Impact Cue Effectiveness? A Comparison of Tonic and Phasic Visual Cueing in Simple and Complex Environments in a Parkinson's Disease Population with Freezing of Gait.

67 The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.

68 "You have to know why you're doing this": a mixed methods study of the benefits and burdens of self-tracking in Parkinson's disease.

69 Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations.

70 The daily lives of people with Parkinson's disease

71 Dopaminergic modulation of the praxis network in Parkinson's disease.

72 Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.

73 Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson's Disease.

74 Brain-First versus Gut-First Parkinson's Disease: A Hypothesis.

75 A Fully Automatic Framework for Parkinson's Disease Diagnosis by Multi-Modality Images.

76 Emergencies in an advanced stage Parkinson's disease patient.

77 Nucleus basalis of Meynert neuronal activity in Parkinson's disease.

78 Study protocol for a single-blind randomised controlled trial to evaluate the clinical effects of an Integrated Qigong exercise intervention on freezing of gait in Parkinson's disease.

79 Metabolic response to Parkinson's disease recapitulated by the haploinsufficient diploid yeast cells hemizygous for the adrenodoxin reductase gene.

80 Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease.

81 Tai Chi and Parkinson's disease (PD): A systematic overview of the scientific quality of the past systematic reviews.

82 'Draw your pelvis' test for assessing pelvic schema in people with Parkinson's disease: a validity and reliability study.

83 Altered Global Synchronizations in Patients With Parkinson's Disease: A Resting-State fMRI Study.

84 Communication impairment in Parkinson's disease: Impact of motor and cognitive symptoms on speech and language.

85 COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.

86 Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study

87 Somatosensory Training Improves Proprioception and Untrained Motor Function in Parkinson's Disease.

88 New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease.

89 Impact of orthostatic hypotension on wheelchair use in patients with Parkinson's disease.

90 [Subjective and objective subtypes of excessive daytime sleepiness in Parkinson's disease].

91 Glial cells in intracerebral transplantation for Parkinson's disease.

92 Perceived effects of Tango Argentino on body experience in persons with Parkinson's disease (PD)-A qualitative study with affected persons and their partners.

93 Comparison of Spontaneous Motor Tempo during Finger Tapping, Toe Tapping and Stepping on the Spot in People with and without Parkinson's Disease.

94 Endoplasmic reticulum stress, an important factor in the development of Parkinson's disease.

95 [The diagnostic value of tremor analysis for defining the Parkinson's disease subtype].

96 [Delirium in idiopathic Parkinson's disease].

97 Effects on goal directed behavior and habit in two animal models of parkinson's disease.

98 Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson's Disease

99 Genetics of Parkinson's disease: An introspection of its journey towards precision medicine

100 The Edmond J. Safra visiting nurse faculty program: An innovative model to enhance faculty development and nursing education on parkinson's disease

101 Medication Safety of Patients With Parkinson's Disease During Care Transitions: Educating Nursing Students.